Clinical Trial Update: Alkagin Paste in the Prevention of Radiation Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial of Alkagin Paste to prevent radiation dermatitis in patients with anal, rectal, and other urogenital cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Rectal Cancer
• Urogenital Cancers

Drugs mentioned

• Alkagin Paste

Snippet

Sponsor: Dr. Te Vuong | Conditions: Anus Neoplasms, Rectal Neoplasms | Phase 2 | Status: TERMINATED